Lipid-based nano-delivery systems for skin delivery of drugs and bioactives

Frontiers in Pharmacology

Volumn 6, Issue SEP, 2015, Pages

  Hua, Susan ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Dermal drug delivery; Ethosomes; Lipid based nano delivery system; Liposomes; Niosomes; Transdermal drug delivery; Transfersomes

Indexed keywords

ALCOHOL; ESTRADIOL; FIBROBLAST GROWTH FACTOR 1; LIPOSOME; LOPERAMIDE; NANOPARTICLE; NIOSOME; PLASMID DNA; TOPICAL AGENT;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CHEMICAL COMPOSITION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; GEL; HUMAN; IN VIVO GENE TRANSFER; INFLAMMATORY PAIN; LIPID BASED NANO DELIVERY SYSTEM; LIPID VESICLE; LIPOSOMAL GENE DELIVERY SYSTEM; NANOENCAPSULATION; NONHUMAN; NOTE; PARTICLE SIZE; PHOSPHOLIPID VESICLE; SKIN INJURY; SKIN PERMEABILITY; WOUND HEALING;

EID: 84944739642     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00219     Document Type: Note

References (34)

1. Bouwstra, J. A., and Ponec, M. (2006). The skin barrier in healthy and diseased state. Biochim. Biophys. Acta 1758, 2080-2095. doi: 10.1016/j.bbamem.2006.06.021
2. Bouwstra, J. A., Honeywell-Nguyen, P. L., Gooris, G. S., and Ponec, M. (2003). Structure of the skin barrier and its modulation by vesicular formulations. Prog. Lipid Res. 42, 1-36. doi: 10.1016/S0163-7827(02)00028-0
3. Bozzuto, G., and Molinari, A. (2015). Liposomes as nanomedical devices. Int. J. Nanomedicine 10, 975-999. doi: 10.2147/IJN.S68861
4. Cevc, G., and Blume, G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1104, 226-232. doi: 10.1016/0005-2736(92)90154-E
5. Cevc, G., and Blume, G. (2001). New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta 1514, 191-205. doi: 10.1016/S0005-2736(01)00369-8
6. Chiechi, L. M. (2004). Estrasorb. IDrugs 7, 860-864.
7. Cosco, D., Celia, C., Cilurzo, F., Trapasso, E., and Paolino, D. (2008). Colloidal carriers for the enhanced delivery through the skin. Expert Opin. Drug Deliv. 5, 737-755. doi: 10.1517/17425247.5.7.737
8. Dubey, V., Mishra, D., Nahar, M., and Jain, N. K. (2007). Vesicles as tools for the modulation of skin permeability. Expert Opin. Drug Deliv. 4, 579-593. doi: 10.1517/17425247.4.6.579
9. El Maghraby, G. M., and Williams, A. C. (2009). Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin. Expert Opin. Drug Deliv. 6, 149-163. doi: 10.1517/17425240802691059
10. El Maghraby, G. M., Barry, B. W., and Williams, A. C. (2008). Liposomes and skin: from drug delivery to model membranes. Eur. J. Pharm. Sci. 34, 203-222. doi: 10.1016/j.ejps.2008.05.002
11. Elsayed, M. M., Abdallah, O. Y., Naggar, V. F., and Khalafallah, N. M. (2007). Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int. J. Pharm. 332, 1-16. doi: 10.1016/j.ijpharm.2006.12.005
12. Elsayed, M. M., Abdallah, O. Y., Naggar, V. F., and Khalafallah, N. M. (2006). Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int. J. Pharm. 322, 60-66. doi: 10.1016/j.ijpharm.2006.05.027
13. Geusens, B., Strobbe, T., Bracke, S., Dynoodt, P., Sanders, N., Van Gele, M., et al. (2011). Lipid-mediated gene delivery to the skin. Eur. J. Pharm. Sci. 43, 199-211. doi: 10.1016/j.ejps.2011.04.003
14. Hofland, H. E., Bouwstra, J. A., Boddé, H. E., Spies, F., and Junginger, H. E. (1995). Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies. Br. J. Dermatol. 132, 853-866. doi: 10.1111/j.1365-2133.1995.tb16940.x
15. Honeywell-Nguyen, P. L., and Bouwstra, J. A. (2005). Vesicles as a tool for transdermal and dermal delivery. Drug Discov. Today Technol. 2, 67-74. doi: 10.1016/j.ddtec.2005.05.003
16. Hua, S. (2014). Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery. Int. J. Nanomedicine 9, 735-744. doi: 10.2147/IJN.S55805
17. Hua, S., and Wu, S. Y. (2013). The use of lipid-based nanocarriers for targeted pain therapies. Front. Pharmacol. 4:143. doi: 10.3389/fphar.2013.00143
18. Iwaszkiewicz, K. S., and Hua, S. (2014). Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the complete freund's adjuvant rodent model of acute inflammatory pain. Pain Physician 17, E719-E735.
19. Kim, A., Lee, E. H., Choi, S. H., and Kim, C. K. (2004). In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials 25, 305-313. doi: 10.1016/S0142-9612(03)00534-9
20. Kirjavainen, M., Urtti, A., Jääskeläinen, I., Suhonen, T. M., Paronen, P., Valjakka-Koskela, R., et al. (1996). Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure. Biochim. Biophys. Acta 1304, 179-189. doi: 10.1016/S0005-2760(96)00126-9
21. Kirjavainen, M., Urtti, A., Valjakka-Koskela, R., Kiesvaara, J., and Mönkkönen, J. (1999). Liposome-skin interactions and their effects on the skin permeation of drugs. Eur. J. Pharm. Sci. 7, 279-286. doi: 10.1016/S0928-0987(98)00037-2
22. Monteiro, N., Martins, A., Reis, R. L., and Neves, N. M. (2014). Liposomes in tissue engineering and regenerative medicine. J. R. Soc. Interface 11, 20140459. doi: 10.1098/rsif.2014.0459
23. Nounou, M. I., El-Khordagui, L. K., Khalafallah, N. A., and Khalil, S. A. (2008). Liposomal formulation for dermal and transdermal drug delivery: past, present and future. Recent Pat. Drug Deliv. Formul. 2, 9-18. doi: 10.2174/187221108783331375
24. Schäfer-Korting, M., Mehnert, W., and Korting, H. C. (2007). Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 59, 427-443. doi: 10.1016/j.addr.2007.04.006
25. Sinkó, B., Garrigues, T. M., Balogh, G. T., Nagy, Z. K., Tsinman, O., Avdeef, A., et al. (2012). Skin-PAMPA: a new method for fast prediction of skin penetration. Eur. J. Pharm. Sci. 45, 698-707. doi: 10.1016/j.ejps.2012.01.011
26. Sun, L., Xu, L., Chang, H., Henry, F. A., Miller, R. M., Harmon, J. M., et al. (1997). Transfection with aFGF cDNA improves wound healing. J. Invest. Dermatol. 108, 313-318. doi: 10.1111/1523-1747.ep12286471
27. Touitou, E., and Ainbinde, D. (2000). 7. Ethosomes-an innovative carrier for enhanced delivery into and across the skin: original research article: ethosomes-novel vesicular carriers for enhanced delivery: characterization skin penetration properties. J. Control. Release 190, 44-46.
28. Touitou, E., Dayan, N., Bergelson, L., Godin, B., and Eliaz, M. (2000). Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release 65, 403-418. doi: 10.1016/S0168-3659(99)00222-9
29. Vanic, Z. (2014). Phospholipid vesicles for enhanced drug delivery in dermatology. J. Drug Discov. Develop Deliv. 1:8.
30. Verma, D. D., Verma, S., Blume, G., and Fahr, A. (2003a). Particle size of liposomes influences dermal delivery of substances into skin. Int. J. Pharm. 258, 141-151. doi: 10.1016/S0378-5173(03)00183-2
31. Verma, D. D., Verma, S., Blume, G., and Fahr, A. (2003b). Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur. J. Pharm. Biopharm. 55, 271-277. doi: 10.1016/S0939-6411(03)00021-3
32. Vora, B., Khopade, A. J., and Jain, N. K. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. J. Control. Release 54, 149-165. doi: 10.1016/S0168-3659(97)00100-4
33. Weissig, V., Pettinger, T. K., and Murdock, N. (2014). Nanopharmaceuticals (part 1): products on the market. Int. J. Nanomedicine 9, 4357-4373. doi: 10.2147/IJN.S46900
34. Yu, H., Wang, Q., Sun, Y., Shen, M., Li, H., and Duan, Y. (2015). A new PAMPA model proposed on the basis of a synthetic phospholipid membrane. PLoS ONE 10:e0116502. doi: 10.1371/journal.pone.0116502